TB Incidence in an Adolescent Cohort in South Africa

• Hassan Mahomed ,

  * E-mail: hmahomed799@gmail.com

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Rodney Ehrlich,

  Affiliations School of Public Health and Family Medicine, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Tony Hawkridge,

  Affiliations Vaccines for Africa Initiative, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Mark Hatherill,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Lawrence Geiter,

  Affiliation Otsuka Pharmaceutical Development and Commercialization, Inc., Rockville, Maryland, United States of America

  ⨯
• Fazlin Kafaar,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Deborah Ann Abrahams,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Humphrey Mulenga,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Michele Tameris,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Hennie Geldenhuys,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Willem Albert Hanekom,

  Affiliations South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, Cape Town, South Africa, School of Child and Adolescent Health, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯
• Suzanne Verver,

  Affiliations KNCV Tuberculosis Foundation, The Hague, The Netherlands and CINIMA, Academic Medical Centre, Amsterdam, The Netherlands, Honorary Research Associate, University of Cape Town, Cape Town, South Africa

  ⨯
• Gregory Dudley Hussey

  Affiliations Vaccines for Africa Initiative, Cape Town, South Africa, University of Cape Town, Cape Town, South Africa

  ⨯